MVIS US Listed Biotech 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that generate at least 50% of their revenues from biotechnology. The pure-play index contains only companies which are engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. The MVIS US Listed Biotech 25 Index (MVBBH) has been licensed to underlie financial products with currently USD 373.35 million in assets under management.

Index Parameters

Market Capitalisation values are updated daily.

Launch Date: 12 Aug 2011
Calculator: Solactive AG
Dissemination: Realtime
Dissemination Period: 09:30 - 16:30 (EST)
Type: Sector
Currency: USD
Current Components: 24
Base Date: 29 Sep 2000
Base Value: 1000
Full Market Cap: 674.39 bn USD
Free-Float Market Cap: 474.73 bn USD
Next Review: 20 Mar 2020

Identifiers

PriceTotal Return NetTotal Return Gross
ISIN:DE000SLA0LB8DE000SLA0LM5DE000SLA1CF6
Sedol:B68L4M6B4QZQM0B8J7XY2
WKN:SLA0LBSLA0LMSLA1CF
Bloomberg:MVBBHMVBBHTRMVBBHTRG
Reuters:.MVBBH.MVBBHTR.MVBBHTRG
Telekurs:CH13624411CH13624412CH20729403
FIGI:BBG001YHPL71BBG001YHPL80BBG00440CW39

Non-Dissemination Days

Following the index methodology as described in the MVIS Global Equity Index Guide, the Index will not be disseminated on the following days:

  • 01 Jan 2019
  • 21 Jan 2019
  • 18 Feb 2019
  • 19 Apr 2019
  • 27 May 2019
  • 04 Jul 2019
  • 02 Sep 2019
  • 28 Nov 2019
  • 25 Dec 2019
Up